Upgrade to SI Premium - Free Trial

Agile Therapeutics (AGRX)

0.60 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/23 *Est.)

Latest Headlines

Form 8-K AGILE THERAPEUTICS INC For: Mar 22 March 25, 2024 4:31 PM - SEC Filing Agile Therapeutics (AGRX) Announces Delisting March 25, 2024 4:30 PM - StreetInsider Agile Therapeutics Announces Delisting from Nasdaq March 25, 2024 4:30 PM - StreetInsider Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024 March 21, 2024 6:35 AM - StreetInsider Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024 March 20, 2024 8:15 AM - StreetInsider Maxim Group Downgrades Agile Therapeutics (AGRX) to Hold March 18, 2024 7:56 AM - StreetInsider Form 8-K AGILE THERAPEUTICS INC For: Mar 13 March 14, 2024 4:45 PM - SEC Filing Agile Therapeutics (AGRX) Completes Pay-off of Debt March 13, 2024 7:31 AM - StreetInsider Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution March 13, 2024 7:31 AM - Globe NewsWire Form 424B5 AGILE THERAPEUTICS INC February 23, 2024 5:00 PM - SEC Filing Form 424B5 AGILE THERAPEUTICS INC February 23, 2024 4:58 PM - SEC Filing Form 8-K AGILE THERAPEUTICS INC For: Feb 22 February 23, 2024 4:37 PM - SEC Filing Agile Therapeutics (AGRX) Receives $4.8M in Warrants Exercise Proceeds February 22, 2024 9:03 AM - StreetInsider Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds February 22, 2024 9:02 AM - StreetInsider Form 8-K AGILE THERAPEUTICS INC For: Feb 09 February 15, 2024 4:46 PM - SEC Filing Agile Therapeutics (AGRX) Granted Nasdaq Extension to Regain Compliance February 15, 2024 4:30 PM - StreetInsider Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update February 15, 2024 4:30 PM - Globe NewsWire Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update February 15, 2024 4:30 PM - StreetInsider Form SC 13G/A AGILE THERAPEUTICS INC Filed by: Lind Global Fund II LP February 13, 2024 8:02 PM - SEC Filing Form S-1/A AGILE THERAPEUTICS INC February 7, 2024 4:52 PM - SEC Filing Form SC 13G/A AGILE THERAPEUTICS INC Filed by: INTRACOASTAL CAPITAL, LLC February 6, 2024 10:15 AM - SEC Filing Form S-1/A AGILE THERAPEUTICS INC February 5, 2024 9:21 AM - SEC Filing Form S-1/A AGILE THERAPEUTICS INC February 2, 2024 4:27 PM - SEC Filing The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost January 23, 2024 9:29 AM - StreetInsider Full Article List